DFX Intelligence

Data Factory

Quva Pharma, Inc

Private Credit

Search this name across graphsid dfx:pc:02d0189c-a1b9-42a9-729a-eeec64b8f9d4

Data as of Jun 30, 2026 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 21, 2026, 8:56 AM UTC and rebuilt at most every 15 minutes.

Relationships: 0
Dated events: 40
On other graphs: 0
Observed: Dec 31, 2021 to Jun 30, 2026
6 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 4
BDCs: 3
Facilities: 2
Principal, latest: $89.9Mpieces as filed; a lower bound
Fair value, latest: $87.5M
Mark ratio: 99%fair value over cost, latest
Next maturity: Apr 1, 2028
First on a schedule: Dec 31, 2021
Last on a schedule: Jun 30, 2026

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
Term loan	First lien	$89.9M	$87.6M	Apr 1, 2028	Html schedule	0	0	3	4	Unknown	Jun 30, 2026
revolver	First lien	n/a	$-130,000	n/a	n/a	n/a	n/a	3	4	Unknown	Jun 30, 2026

Lenders holding it now

each BDC's own pieces on its latest schedule, folded to one row per lender; every amount is that BDC's piece as filed, so a sum is a lower bound; 8 rows folded into 4

BDC	Pieces	Principal	Fair value	Unfunded	Nearest maturity	As of
Blue Owl Capital Corp	2	$68.3M	$66.5M	$5.2M	Apr 1, 2028	Jun 30, 2026
Blue Owl Capital Corp III	2	$16.0M	$16.0M	$567,000	Apr 1, 2026	Sep 30, 2024
Blue Owl Capital Corp II	2	$15.6M	$15.2M	$1.2M	Apr 1, 2028	Jun 30, 2026
Blue Owl Credit Income Corp.	2	$6.0M	$5.8M	$455,000	Apr 1, 2028	Jun 30, 2026

Relationships

No published relationship touches this entity yet.

Dated events

31 bookkeeping events (roster, classification and holdings changes) folded below

Scheduled
Apr 1, 2028
Facility matures inside 24 months
Quva Pharma, Inc term loan (first lien) matures 2028-04-01 (inside 24 months; $89.9M held by 4 BDCs)
BDC schedule of investments
$89.9M
Occurred
Dec 31, 2025
PIK interest added
Quva Pharma, Inc term loan: PIK interest of 3.00% appears (was cash pay)
BDC schedule of investments
$95.3M
Occurred
Dec 31, 2025
Coupon changed
Quva Pharma, Inc term loan: spread moved from 5.50% to 2.75%
BDC schedule of investments
$95.3M
Occurred
Dec 31, 2025
Spread decreased
Blue Owl Capital Corp II: spread decreased in Quva Pharma, Inc (5.50% to 2.75%)
BDC schedule of investmentsobserved 1 months ago
0.0275 usd
Occurred
Dec 31, 2025
Spread decreased
Blue Owl Capital Corp: spread decreased in Quva Pharma, Inc (5.50% to 2.75%)
BDC schedule of investmentsobserved 1 months ago
0.0275 usd
Occurred
Dec 31, 2025
PIK interest added
Blue Owl Capital Corp II: pik added in Quva Pharma, Inc (0.00% to 3.00%)
BDC schedule of investmentsobserved 1 months ago
0.03 usd
Occurred
Dec 31, 2025
PIK interest added
Blue Owl Credit Income Corp.: pik added in Quva Pharma, Inc (0.00% to 3.00%)
BDC schedule of investmentsobserved 1 months ago
0.03 usd
Occurred
Dec 31, 2025
Spread decreased
Blue Owl Credit Income Corp.: spread decreased in Quva Pharma, Inc (5.50% to 2.75%)
BDC schedule of investmentsobserved 1 months ago
0.0275 usd
Occurred
Dec 31, 2025
PIK interest added
Blue Owl Capital Corp: pik added in Quva Pharma, Inc (0.00% to 3.00%)
BDC schedule of investmentsobserved 1 months ago
0.03 usd

Show 31 bookkeeping events

Occurred
Mar 31, 2026
Blue Owl Credit Income Corp.: principal decreased in Quva Pharma, Inc ($5.9M principal)
Occurred
Mar 31, 2026
Blue Owl Capital Corp II: principal decreased in Quva Pharma, Inc ($15.5M principal)
Occurred
Mar 31, 2026
Blue Owl Capital Corp: principal decreased in Quva Pharma, Inc ($67.8M principal)
Occurred
Dec 31, 2025
Blue Owl Capital Corp II: principal decreased in Quva Pharma, Inc ($16.5M principal)
Occurred
Dec 31, 2025
Blue Owl Capital Corp: principal decreased in Quva Pharma, Inc ($72.4M principal)
Occurred
Dec 31, 2025
Blue Owl Credit Income Corp.: principal decreased in Quva Pharma, Inc ($6.3M principal)
Occurred
Jun 30, 2025
Blue Owl Capital Corp: principal increased in Quva Pharma, Inc ($82.5M principal)
Occurred
Jun 30, 2025
Blue Owl Capital Corp II: principal increased in Quva Pharma, Inc ($18.8M principal)
Occurred
Jun 30, 2025
Blue Owl Credit Income Corp.: principal increased in Quva Pharma, Inc ($7.2M principal)
Occurred
Mar 31, 2025
Blue Owl Capital Corp: principal decreased in Quva Pharma, Inc ($5.2M principal)
Occurred
Mar 31, 2025
Blue Owl Credit Income Corp.: principal decreased in Quva Pharma, Inc ($6.8M principal)
Occurred
Mar 31, 2025
Blue Owl Capital Corp: principal decreased in Quva Pharma, Inc ($77.6M principal)
Occurred
Mar 31, 2025
Blue Owl Capital Corp II: principal decreased in Quva Pharma, Inc ($17.7M principal)
Occurred
Dec 31, 2024
Blue Owl Capital Corp: principal increased in Quva Pharma, Inc ($103.9M principal)
Occurred
Dec 31, 2024
Blue Owl Capital Corp II: principal increased in Quva Pharma, Inc ($30.7M principal)
Occurred
Dec 31, 2024
Blue Owl Capital Corp II: principal increased in Quva Pharma, Inc ($1.0M principal)
Occurred
Dec 31, 2024
Blue Owl Capital Corp: principal increased in Quva Pharma, Inc ($6.7M principal)
Occurred
Dec 31, 2024
Blue Owl Credit Income Corp.: principal increased in Quva Pharma, Inc ($11.8M principal)
Occurred
Sep 30, 2024
Blue Owl Capital Corp: principal increased in Quva Pharma, Inc ($52.1M principal)
Occurred
Sep 30, 2024
Blue Owl Capital Corp III: principal increased in Quva Pharma, Inc ($15.4M principal)
Occurred
Sep 30, 2024
Blue Owl Capital Corp II: principal increased in Quva Pharma, Inc ($15.4M principal)
Occurred
Sep 30, 2024
Blue Owl Credit Income Corp.: principal increased in Quva Pharma, Inc ($5.9M principal)
Occurred
Jun 30, 2024
Blue Owl Capital Corp III: principal increased in Quva Pharma, Inc ($.7M principal)
Occurred
Jun 30, 2024
Blue Owl Capital Corp II: principal increased in Quva Pharma, Inc ($.7M principal)
Occurred
Jun 30, 2024
Blue Owl Capital Corp: principal increased in Quva Pharma, Inc ($2.2M principal)
Occurred
Dec 31, 2023
Blue Owl Capital Corp III: principal decreased in Quva Pharma, Inc ($.0M principal)
Occurred
Sep 30, 2023
Blue Owl Capital Corp III: principal decreased in Quva Pharma, Inc ($.3M principal)
Occurred
Sep 30, 2023
Blue Owl Capital Corp II: principal decreased in Quva Pharma, Inc ($.3M principal)
Occurred
Jun 30, 2023
Blue Owl Capital Corp: principal decreased in Quva Pharma, Inc ($1.8M principal)
Occurred
Mar 31, 2023
Blue Owl Capital Corp: principal increased in Quva Pharma, Inc ($2.6M principal)
Occurred
Dec 31, 2022
Blue Owl Credit Income Corp.: new position in Quva Pharma, Inc ($.2M principal)

Provenance

Graph: Private Credit
Canonical id: dfx:pc:02d0189c-a1b9-42a9-729a-eeec64b8f9d4
First observed: Dec 31, 2021
Last observed: Jun 30, 2026 2 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Quva Pharma, Inc

Private Credit

Search this name across graphsid dfx:pc:02d0189c-a1b9-42a9-729a-eeec64b8f9d4

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

Term loan

First lien

$89.9M

$87.6M

Apr 1, 2028

Html schedule

Unknown

Jun 30, 2026

revolver

First lien

n/a

$-130,000

n/a

Unknown

Jun 30, 2026

BDC

Pieces

Principal

Fair value

Unfunded

Nearest maturity

As of

Blue Owl Capital Corp

$68.3M

$66.5M

$5.2M

Apr 1, 2028

Jun 30, 2026

Blue Owl Capital Corp III

$16.0M

$567,000

Apr 1, 2026

Sep 30, 2024

Blue Owl Capital Corp II

$15.6M

$15.2M

$1.2M

Apr 1, 2028

Jun 30, 2026

Blue Owl Credit Income Corp.

$6.0M

$5.8M

$455,000

Apr 1, 2028

Jun 30, 2026